Jefferies Financial Group Inc. Nevro Corp Put Options Transaction History

Jefferies Financial Group Inc.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$4.71 - $10.1 $266,115 - $570,650	-56,500 Reduced 9.71%	525,600 $2.93 Million
Q2 2024 Aug 13, 2024	BUY	$7.96 - $13.59 $2.47 Million - $4.21 Million	309,700 Added 113.69%	582,100 $4.9 Million
Q1 2024 May 13, 2024	BUY	$13.56 - $20.78 $913,944 - $1.4 Million	67,400 Added 32.88%	272,400 $3.93 Million
Q4 2023 Feb 13, 2024	BUY	$14.18 - $22.31 $782,736 - $1.23 Million	55,200 Added 36.85%	205,000 $4.41 Million
Q3 2023 Nov 14, 2023	BUY	$18.22 - $25.85 $1.44 Million - $2.04 Million	78,800 Added 110.99%	149,800 $2.88 Million
Q2 2023 Aug 14, 2023	BUY	$22.62 - $39.32 $248,820 - $432,520	11,000 Added 18.33%	71,000 $1.8 Million
Q4 2022 Sep 21, 2023	SELL	$36.43 - $49.4 $400,730 - $543,400	-11,000 Reduced 15.49%	60,000 $2.38 Million
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $2.19 Million - $2.96 Million	60,000 New	60,000 $2.38 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.